Line 1,313: |
Line 1,313: |
| | | | | |
| |- | | |- |
− | |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| | + | |Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||Laveniya Satgunaseelan |
− | | | + | |26/10/2021 |
− | | | + | |26/1/2022 |
− | | | + | |Pending |
| | ||GC | | | ||GC |
| | | | | |
Line 1,417: |
Line 1,417: |
| | | | | |
| |- | | |- |
− | | Multicentric Castleman Disease||Disease|| | + | | Multicentric Castleman Disease||Disease||Sudha Arumugam |
− | | | + | |10/26/2021 |
− | | | + | |1/26/2022 |
− | | | + | |Pending |
| | ||GC | | | ||GC |
| | | | | |
| | | | | |
| |- | | |- |
− | | HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| | + | | HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sudha Arumugam |
− | | | + | |10/26/2021 |
− | | | + | |1/26/2022 |
− | | | + | |Pending |
| | ||GC | | | ||GC |
| | | | | |
| | | | | |
| |- | | |- |
− | | HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease|| | + | | HHV8-Positive Germinotropic Lymphoproliferative Disorder||Disease||Sudha Arumugam |
− | | | + | |10/26/2021 |
− | | | + | |1/26/2022 |
− | | | + | |Pending |
| | ||GC | | | ||GC |
| | | | | |